Patent · US Active

Process methods for phosphatidylinositol 3-kinase inhibitors

US9567337B2 · kind B2 · utility

9Cited by
64References
44Claims
0Family size

Inventors

Key dates

Filing dateDec 18, 2014
Grant dateFeb 14, 2017
Priority date
Expiry dateDec 18, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound intermediates relating to these processes are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.